InsidersTradesSigma
Total declarations
Company
▲ Purchases (2 ops.)
▼ Sales (0 ops.)
Browse the complete record of transactions filed by Jones John Philip, Chief Financial Officer. Officer active across 1 companies, notably Alimera Sciences INC. In total, 9 disclosures have been logged. Total volume traded: €35k. The latest transaction was filed on 29 April 2022 (Attribution). Regulator: SEC (Form 4). All data is openly available.
Declarations9 total
€1,524426 shares@ €3.57673.6% of flow
Common Stock
SEC:0001474506-22-000038:0·
08,750 shares0
Common Stock
SEC:0001474506-22-000010·
08,750 shares0
Common Stock
SEC:0001474506-22-000010:0·
€17,6175,000 shares@ €3.523387.5% of flow
Common Stock
SEC:0001474506-21-000158·
Ideal exit: 31 Jul 2022 (T+270)
€17,6175,000 shares@ €3.523342.1% of flow
Common Stock
SEC:0001474506-21-000158:0·
Ideal exit: 31 Jul 2022 (T+270)
€1,283399 shares@ €3.21566.4% of flow
Common Stock
SEC:0001474506-21-000154·
€1,283399 shares@ €3.21563.1% of flow
Common Stock
SEC:0001474506-21-000154:0·
€1,236421 shares@ €2.93686.1% of flow
Common Stock
SEC:0001474506-21-000083·
€1,236421 shares@ €2.93683.0% of flow
Common Stock
SEC:0001474506-21-000083:0·
9 of 9 declarations
About Jones John Philip
John Philip Jones is the Chief Financial Officer at ALIMERA SCIENCES INC. He is responsible for the financial management of the company, including financial planning and analysis. His role is crucial for ensuring financial health and supporting the company's growth.
